Drug Shortage Report for AVAPRO

Last updated on 2022-06-27 History
Report ID 151325
Drug Identification Number 02237923
Brand name AVAPRO
Common or Proper name Avapro
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 75MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 90
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-01-17
Actual start date
Estimated end date 2022-09-30
Actual end date
Shortage status Actual shortage
Updated date 2022-06-27
Company comments Manufacturing Issue. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-06-27 French Compare
v8 2022-06-27 English Compare
v7 2022-05-10 French Compare
v6 2022-05-10 English Compare
v5 2022-01-21 French Compare
v4 2022-01-21 English Compare
v3 2022-01-18 English Compare
v2 2021-12-16 French Compare
v1 2021-12-16 English Compare

Showing 1 to 9 of 9